Search
Returning search results with filters:
Remove filter for
Issue: New safety information
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20221 results available
- October 20222 results available
- September 20222 results available
- August 20221 results available
- July 20221 results available
- May 20221 results available
- April 20222 results available
- March 20221 results available
- February 20222 results available
- January 20223 results available
Displaying 16 - 16 of 16 items.
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
AlertHealth professional risk communication | 2022-01-07